Viatris, Inc. (VTRS)
16.51
+0.13
(+0.79%)
USD |
NASDAQ |
Sep 11, 16:00
16.52
0.00 (0.00%)
After-Hours: 20:00
Viatris Market Cap : 19.07B for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 19.07B |
| September 10, 2026 | 18.92B |
| September 09, 2026 | 19.06B |
| September 08, 2026 | 19.19B |
| September 04, 2026 | 19.50B |
| September 03, 2026 | 19.57B |
| September 02, 2026 | 19.74B |
| September 01, 2026 | 19.21B |
| August 31, 2026 | 19.07B |
| August 28, 2026 | 18.88B |
| August 27, 2026 | 19.51B |
| August 26, 2026 | 19.47B |
| August 25, 2026 | 19.32B |
| August 24, 2026 | 19.11B |
| August 21, 2026 | 18.85B |
| August 20, 2026 | 18.62B |
| August 19, 2026 | 18.77B |
| August 18, 2026 | 18.68B |
| August 17, 2026 | 18.75B |
| August 14, 2026 | 18.75B |
| August 13, 2026 | 18.53B |
| August 12, 2026 | 18.60B |
| August 11, 2026 | 18.81B |
| August 10, 2026 | 18.81B |
| August 07, 2026 | 18.98B |
| Date | Value |
|---|---|
| August 06, 2026 | 18.82B |
| August 05, 2026 | 20.39B |
| August 04, 2026 | 20.45B |
| August 03, 2026 | 20.37B |
| July 31, 2026 | 20.29B |
| July 30, 2026 | 20.52B |
| July 29, 2026 | 20.59B |
| July 28, 2026 | 20.63B |
| July 27, 2026 | 20.37B |
| July 24, 2026 | 19.92B |
| July 23, 2026 | 19.96B |
| July 22, 2026 | 19.65B |
| July 21, 2026 | 20.32B |
| July 20, 2026 | 19.63B |
| July 17, 2026 | 19.97B |
| July 16, 2026 | 20.02B |
| July 15, 2026 | 19.27B |
| July 14, 2026 | 18.84B |
| July 13, 2026 | 18.93B |
| July 10, 2026 | 18.80B |
| July 09, 2026 | 18.88B |
| July 08, 2026 | 19.25B |
| July 07, 2026 | 19.59B |
| July 06, 2026 | 19.41B |
| July 02, 2026 | 19.29B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 1.050T |
| Pfizer Inc. | 157.98B |
| Merck & Co., Inc. | 355.31B |
| Bristol Myers Squibb Co. | 130.02B |
| Johnson & Johnson | 639.58B |
Market Cap Related Metrics
| PS Ratio | 1.303 |
| Price to Book Value | 1.338 |
| Price to Free Cash Flow | 10.64 |
| Price | 16.51 |
| Earnings Yield | -2.16% |
| Operating PE Ratio | 13.45 |
| Normalized PE Ratio | 32.71 |